Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Prostate Cancer Diagnosis and Treatment

TopicLeading institutions, researchers & key papers

This cluster of papers encompasses a wide range of research on prostate cancer, including screening methods, treatment options such as radiation therapy and surgery, use of MRI imaging for detection, genetic factors, and clinical guidelines for management. The papers also cover topics like Gleason grading, androgen suppression, biopsy techniques, and long-term survival rates.

459
Works

How has Prostate Cancer Diagnosis and Treatment's publication output changed over time?

ScholarIQpublication output · 2000–2020

Output grew0% over the shown period — from 1 works in 2000 to 1 in 2020.

1
1
1
1
2
1
1
2
3
1
2000200620092011201220142015201620182020

What are the most-cited papers on Prostate Cancer Diagnosis and Treatment?

ScholarIQmost cited works
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa, Louis Denis, Franz Recker, Antonio Berenguer, Liisa Määttänen, Chris H. Bangma, Gunnar Aus, Arnauld Villers, Xavier Rebillard, Theodorus van der Kwast, B. G. Blijenberg, Sue M. Moss, Harry J. de Koning, Anssi Auvinen
New England Journal of Medicine. 20094,027 CitationsOPEN ACCESS
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan, Antti Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard Hindley, Monique J. Roobol, Scott E. Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert Villeirs, Jaspal Virdi, Silvan Boxler, G. Robert, Paras B. Singh, Wulphert Venderink, Boris Hadaschik, A. Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter A. Pinto, Inderbir S. Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman Williams, Chris Brew‐Graves, Jonathan J Deeks, Yemisi Takwoingi, Mark Emberton, Caroline M. Moore
New England Journal of Medicine. 20183,062 CitationsOPEN ACCESS
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler
International Journal of Radiation Oncology*Biology*Physics. 20062,750 Citations
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Freddie C. Hamdy, Jenny Donovan, J. Athene Lane, Malcolm D. Mason, Chris Metcalfe, Peter Holding, Michael Davis, T. J. Peters, Emma L. Turner, Richard M. Martin, Jon Oxley, Mary Robinson, John Staffurth, Eleanor Walsh, Prasad Bollina, James W.F. Catto, Andrew Doble, Alan Doherty, David Gillatt, Roger Kockelbergh, Howard Kynaston, Alan Paul, Philip Powell, Stephen M. Prescott, Derek J. Rosario, Edward Rowe, David E. Neal
New England Journal of Medicine. 20162,661 CitationsOPEN ACCESS
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad Martin, Mark Frydenberg, Ramdave Shakher, Lih‐Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marušić, A Matera, Alan Herschtal, Amir Iravani, Rodney J. Hicks, Scott Williams, Declan G. Murphy
The Lancet. 20202,004 Citations

Where is Prostate Cancer Diagnosis and Treatment research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Prostate Cancer Diagnosis and Treatment is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
27%
Hybrid
7%
Bronze
33%
Closed
33%

Related on ScholarIQ

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Paper
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Paper
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Paper
Screening and Prostate-Cancer Mortality in a Randomized European Study
Paper
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
Paper
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Paper
470M+ articles · free account